Roundup Cancer Lawsuit Update

What the Roundup Cancer lawsuit is about

Roundup lawsuits allege that glyphosate-based herbicide exposure caused non-Hodgkin lymphoma and that warnings were inadequate. Monsanto/Bayer disputes the claims. Federal MDL-2741 proceedings, the proposed Missouri King class settlement and individual state cases are distinct proceedings.

Roundup lawsuit and settlement update: October 2026

Proposed class settlement still awaiting an approval decision. The King v. Monsanto fairness hearing was held September 14, 2026. As of October 23, the official administrator's FAQ says the court will now decide whether to approve the settlement and the amount of fees to award, and that it does not know how long those decisions will take. Settlement registration does not open until after final approval. The separate federal MDL remains before Judge Vince Chhabria.

On September 29, a Missouri state court in St. Louis opened a trial for three non-Hodgkin lymphoma plaintiffs who are not part of the settlement. Their claims rely on design-defect and inadequate-testing theories, which the Supreme Court's Durnell ruling on label warnings did not directly address (Reuters via Claims Journal). Monsanto disputes the claims.

The October 1, 2026 JPML report lists 1,104 pending actions in MDL-2741, compared with 3,925 on September 1. The JPML report does not explain the drop. Its 5,324 total historical actions include cases no longer pending; neither figure is a count of people eligible for payment.

Official court records checked September 14, 2026; settlement administrator FAQ checked October 23, 2026.

Has the King v. Monsanto settlement received final approval?

No final approval order had been posted as of October 23, 2026. The fairness hearing took place September 14, 2026. The court-appointed administrator's FAQ says the court will now decide whether to approve the settlement and, if so, what fees to award, and that the administrator does not know how long those decisions will take.

What final approval would start, according to the administrator's FAQ:

• Subclass 1 (diagnosed with non-Hodgkin lymphoma before March 4, 2026): registration due within 180 days after the court grants final approval, and a claim package due no later than 180 days after the settlement becomes final. Exact dates are to be posted after approval.
• Subclass 2 (diagnosed after March 4, 2026): no registration step; a claim package is due within six years of diagnosis and before the 16th annual payment date.

Final approval is not the same as payment. Appeals, claim review, and the settlement's annual payment structure all affect when money is paid. Check WeedKillerClass.com or the administrator's phone line for official dates; this site does not process claims.

Case status snapshot

• Federal proceeding: MDL-2741; U.S. District Court, Northern District of California
• Judge: Judge Vince Chhabria
• JPML transfer date: 2016-10-03
• Pending actions: 1,104 as of October 1, 2026
• Current phase: Proposed class settlement awaiting approval decision
• Settlement: The proposed King v. Monsanto class settlement provides up to $7.25 billion, subject to final approval. The fairness hearing was held September 14, 2026; the administrator says the court will now decide whether to approve the settlement and that the timing is unknown.

Who may qualify for a Roundup lawsuit?

Roundup use by itself does not establish that someone has a viable individual lawsuit. A claim review generally considers whether the product and exposure can be identified, whether medical records document non-Hodgkin lymphoma, whether the timeline fits the claim being evaluated, and whether state law or earlier Roundup paperwork affects the person's options.

The proposed King v. Monsanto class uses its own court-defined membership and award rules. Being included in that proposed class is not the same legal question as whether someone can file or continue an individual personal-injury or wrongful-death lawsuit. The official settlement FAQ also treats certain people with pending MDL claims, earlier settlements, releases, judgments, or dismissals differently.

Common individual-claim review factors include:

• Identifiable exposure: The Roundup or glyphosate-containing product, approximate years of use, frequency, duration, and whether exposure occurred at work, at home, or both.
• Exposure circumstances: Applying or mixing the product, cleaning equipment, handling concentrate, spills, overspray, skin contact, inhalation, and protective equipment.
• Documented diagnosis: Pathology and oncology records showing non-Hodgkin lymphoma, the subtype, diagnosis date, treatment, recurrence, or death where relevant.
• Complete timeline: First and last exposure, diagnosis, treatment, recurrence, death, and the date the person first connected the diagnosis with the alleged exposure.
• Prior legal activity: Earlier lawsuits, tolling agreements, settlements, releases, judgments, dismissals, class notices, or opt-out paperwork.
• Applicable law: The state and claim type that may control filing deadlines, available legal theories, and wrongful-death or survival issues.

Agricultural work, landscaping, groundskeeping, nursery work, golf-course maintenance, municipal weed control, parks or school maintenance, and repeated homeowner use can produce different exposure records. These factors help organize a review; they are not an automatic qualification formula, and this site cannot decide whether a person has a claim.

Verified litigation updates

• JPML reports 1,104 pending actions on October 1, 2026, compared with 3,925 on September 1; 5,324 total historical actions are reported separately. Source
• A St. Louis state-court trial for three plaintiffs outside the settlement opened September 29 on design-defect and inadequate-testing theories. Source
• The fairness hearing was held September 14; as of October 23 the administrator says the court will now decide whether to approve the settlement, with timing unknown. Source
• The administrator lists June 4, 2026 as the objection and exclusion deadline; later benefit deadlines depend on final approval and appeals. Source
• The Supreme Court decided Monsanto v. Durnell on June 25, 2026, holding the label-based failure-to-warn claim at issue expressly preempted by FIFRA. Source

When did the Roundup lawsuit start?

For people asking when the Roundup lawsuit started, there are two useful ways to think about the timeline. Individual product use and cancer diagnoses may date back many years, while the federal Roundup multidistrict litigation became a centralized national proceeding in 2016. That federal coordination is important because it helped organize common pretrial issues in many Roundup product liability cases.

The broader litigation has continued through trials, appeals, settlement programs, state court activity, and ongoing disputes over warnings, causation, preemption, releases, and settlement procedures. Because the litigation has a long history, a current claim review may need to look backward at exposure years, diagnosis date, prior claim participation, and whether any settlement or release paperwork already exists.

The start date of the litigation does not answer whether a claim is timely. A person diagnosed years ago may face different deadline questions than someone with a more recent diagnosis, and those questions may depend on state law and individual discovery facts.

Roundup lawsuit status

The King v. Monsanto fairness hearing was held September 14, 2026. The official administrator says the court will now decide whether to approve the settlement and that the timing is unknown. The separate federal MDL remains before Judge Vince Chhabria.

The proposed class settlement provides up to $7.25 billion, subject to final approval. June 4 objection and opt-out deadlines have passed. Registration and claim deadlines depend on later approval and appeal events; they are separate from state lawsuit deadlines.

Key issues in the lawsuit

Roundup lawsuits generally focus on whether repeated exposure to glyphosate-based herbicides can be linked to non-Hodgkin lymphoma and whether Monsanto or related defendants adequately warned users about alleged cancer risks. Plaintiffs may include agricultural workers, landscapers, groundskeepers, homeowners, nursery workers, parks employees, school or municipal workers, and others who used or handled Roundup repeatedly.

The key factual issues include how often the person used Roundup, whether exposure was occupational or residential, whether the person mixed concentrate or used ready-to-use products, what protective equipment was used, and whether the diagnosis is a type of non-Hodgkin lymphoma being evaluated. Legal issues may include warning adequacy, causation, federal preemption arguments, state-law deadlines, settlement releases, and proof of damages.

Defendants may argue that regulatory labeling was adequate, that scientific evidence does not prove causation for a particular person, that exposure was too limited, or that other risk factors explain the cancer. Plaintiffs may point to repeated use, product history, diagnosis records, and expert causation evidence.

Roundup claims can also turn on the difference between casual product use and repeated exposure. A homeowner who sprayed weeds once or twice may present a different review than a worker who mixed concentrate, sprayed large areas, cleaned equipment, or handled the product as part of routine job duties over many seasons.

What proof do you need for a Roundup lawsuit?

No single receipt, photograph, or medical record proves that someone qualifies. A useful review usually combines evidence identifying the product and exposure with records confirming the diagnosis and dates that may control timeliness.

• Product and exposure records: Purchase receipts, product or container photographs, EPA registration numbers, application logs, invoices, farm records, property-maintenance records, job descriptions, payroll records, employer records, and witness statements.
• Exposure details: Approximate first and last use, frequency, hours or days of use, whether concentrate was mixed, tasks performed, protective equipment, and whether exposure occurred at work or home.
• Medical records: Pathology reports, biopsy results, oncology records, records naming the lymphoma subtype, treatment records, recurrence records, and death records where applicable.
• Timing and legal documents: Diagnosis and treatment dates plus any lawsuit, tolling agreement, settlement, release, judgment, dismissal, class notice, or opt-out record.

Missing receipts do not automatically decide the issue. Other records may help document product use, but vague memories or unidentified weed-killer exposure can make review more difficult. A person gathering records should preserve the originals and avoid guessing at dates or product names.

When will Roundup settlement checks be paid?

There is no single payment date for all Roundup claims. Earlier settlements, individual state-court cases, MDL cases, and the proposed 2026 nationwide class settlement may follow different timelines. The fairness hearing was held September 14, but final approval remains pending and the administrator says the decision timing is unknown. Any final order, appeal, eligibility review, claim administration, release, and individual documentation can affect timing.

For individual claims, a payment timeline may depend on whether the claim is already resolved, whether a release was signed, whether lien resolution is required, and whether the person is participating in a specific settlement program. Search results that promise a universal payout date should be treated cautiously unless they cite the settlement administrator, court order, or docket.

What is the deadline to file a Roundup lawsuit?

There is no single national deadline for an individual Roundup lawsuit. A filing deadline may depend on the governing state's statute of limitations or repose, the legal claim, diagnosis and discovery facts, a death date in wrongful-death or survival matters, and any earlier lawsuit, tolling agreement, settlement, release, judgment, or dismissal.

The federal MDL does not create one filing period for every person nationwide. Questions about whether time runs from product use, symptoms, diagnosis, discovery, or death require state-specific legal analysis. Because Roundup litigation has been public for years, waiting to identify the relevant dates can create additional risk.

Class-settlement dates do not replace an individual lawsuit deadline. The proposed King v. Monsanto settlement has a separate court-controlled schedule. Its official website says the June 4, 2026 deadline to object or request exclusion has passed. The administrator says the court will now decide whether to approve the settlement; benefit deadlines have not begun.

If the proposed settlement receives final approval and becomes effective, people who are class members and did not opt out may be bound by its release and may lose the ability to pursue covered claims outside the settlement program, subject to the settlement's terms and exceptions. That possible consequence is separate from whether a state statute of limitations has expired.

The proposed class also describes later registration and claim-submission periods if the settlement becomes final. Those program dates concern settlement participation; they do not establish whether an individual personal-injury, wrongful-death, or survival claim was timely filed under applicable state law.

To prepare for a deadline review, gather the earliest supportable dates for:

• first and last Roundup or glyphosate-product exposure;
• symptoms, diagnosis, pathology, treatment, and recurrence;
• death and appointment of an estate representative, where applicable;
• states where exposure, residence, diagnosis, and treatment occurred; and
• prior claims, tolling agreements, settlements, releases, judgments, dismissals, or class notices.

The state guide links on this page provide general state context, but they cannot calculate a deadline for a particular person. A licensed attorney must determine which law and date apply.

Questions to ask before contacting a lawyer

• Can I identify the Roundup or glyphosate product I used?
• Was my exposure occupational, residential, agricultural, or landscaping-related?
• How often did I apply the product, and for how many years?
• What type of non-Hodgkin lymphoma was diagnosed, and when?
• Have I signed any settlement, release, or claim paperwork before?
• Which state deadline rules may apply to my exposure and diagnosis timeline?

Sources and status notes

Counts use the October 1 JPML report and September 1 report. Court assignments and transfer dates use the JPML by-number report. Status was checked September 14, 2026 against public court records; these public indexes are not complete live dockets.

• The fairness hearing was held September 14; the court's approval decision remains pending with timing unknown.
• The administrator lists June 4, 2026 as the objection and exclusion deadline; later benefit deadlines depend on final approval and appeals.
• The Supreme Court decided Monsanto v. Durnell on June 25, 2026, holding the label-based failure-to-warn claim at issue expressly preempted by FIFRA.

Defendants dispute the allegations. Hearing schedules do not establish an outcome, and pending-action counts do not establish settlement eligibility. State filing deadlines and settlement-program deadlines are different.

Where can I track the Roundup Cancer lawsuit?

Use the mass tort settlement tracker to compare public settlement posture, the deadline tracker for filing-window and key-date notes , and the MDL statistics tracker for federal case counts and court assignments.

What injuries does the Roundup Cancer lawsuit involve?

• Non-Hodgkin lymphoma
• Glyphosate exposure
• Agricultural exposure
• Landscaping or groundskeeping exposure

What evidence is needed for Roundup Cancer claims?

• Product use history
• Employment or groundskeeping records
• Purchase records
• Medical diagnosis records
• Oncology records
• Treatment records

How has the Roundup Cancer lawsuit progressed?

What is the Roundup Cancer settlement status?

The proposed King v. Monsanto class settlement provides up to $7.25 billion, subject to final approval. The fairness hearing was held September 14, 2026; the administrator says the court will now decide whether to approve the settlement and that the timing is unknown. June 4 objection and opt-out deadlines have passed.

What are the Roundup Cancer lawsuit filing deadlines?

Deadlines vary by state and may depend on diagnosis date, discovery date, exposure history, wrongful death issues, and other facts. A lawyer can evaluate how the relevant deadline rules may apply.

State-by-state guide links